We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+8.38%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.84B
AUM Growth
-$2.1B
Cap. Flow
-$2.45B
Cap. Flow %
-63.69%
Top 10 Hldgs %
22.61%
Holding
6,382
New
824
Increased
1,880
Reduced
2,765
Closed
701

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$120M
2
MSFT icon
Microsoft
MSFT
+$115M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$72.4M
4
AMZN icon
Amazon
AMZN
+$69.8M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$51.2M

Sector Composition

Rank Sector Weight
1 Technology 19.05%
2 Consumer Discretionary 11.67%
3 Healthcare 9.59%
4 Financials 9.24%
5 Communication Services 7.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADTN icon
3376
Adtran
ADTN
$632M
$33K ﹤0.01%
1,615
-2,143
-57% -$41.4K
AGX icon
3377
Argan
AGX
$8.11B
$33K ﹤0.01%
682
-434
-39% -$21.6K
ATOM icon
3378
Atomera
ATOM
$217M
$33K ﹤0.01%
1,512
-1,038
-41% -$21.3K
BBSI icon
3379
Barrett Business Services
BBSI
$761M
$33K ﹤0.01%
1,820
-2,984
-62% -$54.6K
BRBR icon
3380
BellRing Brands
BRBR
$1.34B
$33K ﹤0.01%
1,052
-1,663
-61% -$45.4K
CLS icon
3381
Celestica
CLS
$39.1B
$33K ﹤0.01%
4,196
+3,469
+477% +$28.9K
GPGI
3382
GPGI Inc
GPGI
$4.11B
$33K ﹤0.01%
3,941
+2,804
+247% +$23.5K
DCOM icon
3383
Dime Commercial Bancshares
DCOM
$1.79B
$33K ﹤0.01%
987
-1,521
-61% -$51.2K
DHC
3384
Diversified Healthcare Trust
DHC
$1.98B
$33K ﹤0.01%
7,880
-17,098
-68% -$70.6K
FMS icon
3385
Fresenius Medical Care
FMS
$12.7B
$33K ﹤0.01%
786
+474
+152% +$18.9K
GALT icon
3386
Galectin Therapeutics
GALT
$316M
$33K ﹤0.01%
10,202
+5,138
+101% +$18.3K
GBTG icon
3387
American Express Global Business Travel
GBTG
$4.93B
$33K ﹤0.01%
3,340
+2,440
+271% +$24K
GNSS icon
3388
Genasys
GNSS
$76.1M
$33K ﹤0.01%
5,944
+1,039
+21% +$6.34K
HLIT icon
3389
Harmonic Inc
HLIT
$1.24B
$33K ﹤0.01%
3,943
-3,860
-49% -$29.6K
HWKN icon
3390
Hawkins
HWKN
$2.71B
$33K ﹤0.01%
986
-262
-21% -$8.68K
MGPI icon
3391
MGP Ingredients
MGPI
$393M
$33K ﹤0.01%
490
-512
-51% -$33.5K
MMYT icon
3392
MakeMyTrip
MMYT
$5.78B
$33K ﹤0.01%
1,088
+959
+743% +$26.6K
NEWT icon
3393
NewtekOne
NEWT
$368M
$33K ﹤0.01%
947
-335
-26% -$10.5K
OFLX icon
3394
Omega Flex
OFLX
$302M
$33K ﹤0.01%
223
+17
+8% +$2.57K
OXLC
3395
Oxford Lane Capital
OXLC
$910M
$33K ﹤0.01%
896
+489
+120% +$17.1K
RCON icon
3396
Recon Technology
RCON
$2.81M
$33K ﹤0.01%
+424
New +$61.7K
RLMD icon
3397
Relmada Therapeutics
RLMD
$477M
$33K ﹤0.01%
1,041
-757
-42% -$26.3K
SNFCA icon
3398
Security National Financial
SNFCA
$243M
$33K ﹤0.01%
5,036
+3,014
+149% +$19.2K
STKS icon
3399
The ONE Group
STKS
$56.5M
$33K ﹤0.01%
2,999
+976
+48% +$9.9K
TTGT icon
3400
TechTarget
TTGT
$271M
$33K ﹤0.01%
423
-1,620
-79% -$116K

Similar funds

Tower Research Capital (TRC)'s Q2 2021 Portfolio in Review

As of Q2 2021, Tower Research Capital (TRC) held 6,382 positions worth $3.84B, down 35% from $5.94B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Tower Research Capital (TRC) withdrew a net $2.45B in Q2 2021, closing 701 positions and reducing 2,765 holdings. Its most notable exit was iShares Russell 1000 Growth ETF, an estimated $15.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in Invesco NASDAQ Biotechnology ETF worth $8.44M.

  • Tower Research Capital (TRC)'s largest Q2 2021 buy was Invesco NASDAQ Biotechnology ETF: 325,629 shares worth $8.44M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $175M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2021 reduction was Apple, cutting an estimated $120M.
  • Tower Research Capital (TRC) fully exited iShares Russell 1000 Growth ETF in Q2 2021, selling an estimated $15.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 23% of its $3.84B portfolio in Q2 2021.
  • Tower Research Capital (TRC) opened 824 new positions and closed 701 in Q2 2021.
  • Tower Research Capital (TRC)'s portfolio value fell 35% quarter-over-quarter to $3.84B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2021, filed 16 Aug 2021.